T. Rowe Price Investment Management’s Procept Biorobotics PRCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$81.9M Buy
3,273,794
+2,386
+0.1% +$67.2K 0.06% 283
2025
Q4
$103M Buy
3,271,408
+1,218,815
+59% +$40.4M 0.07% 249
2025
Q3
$73.3M Buy
2,052,593
+524,766
+34% +$24M 0.04% 324
2025
Q2
$88M Buy
1,527,827
+112,424
+8% +$6.36M 0.06% 298
2025
Q1
$82.5M Buy
1,415,403
+429,461
+44% +$29.3M 0.05% 313
2024
Q4
$79.4M Sell
985,942
-45,785
-4% -$3.91M 0.05% 329
2024
Q3
$82.7M Sell
1,031,727
-715,362
-41% -$50.8M 0.05% 332
2024
Q2
$107M Sell
1,747,089
-1,192,830
-41% -$70.9M 0.07% 274
2024
Q1
$145M Sell
2,939,919
-755,108
-20% -$35.9M 0.09% 232
2023
Q4
$155M Buy
3,695,027
+44,928
+1% +$1.53M 0.1% 216
2023
Q3
$120M Buy
3,650,099
+622,432
+21% +$21.2M 0.08% 239
2023
Q2
$107M Buy
3,027,667
+302,378
+11% +$10M 0.07% 261
2023
Q1
$77.4M Buy
2,725,289
+27,404
+1% +$967K 0.06% 300
2022
Q4
$112M Buy
2,697,885
+124,102
+5% +$5.33M 0.09% 237
2022
Q3
$107M Buy
+2,573,783
New +$103M 0.09% 230

Other funds holding PRCT